Longboard Pharmaceuticals, Inc.
LBPHDelisted Dec 2, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001832168
Longboard Pharmaceuticals, Inc. was delisted on Dec 2, 2024; its insiders filed their last Form 4 on Dec 2, 2024; 125 institutions reported holding it in 13F filings for Q3 2024, worth $1.33B in total; Viking Global Investors was the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Longboard Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 22 | 17 | −5 |
| Shares | 8.90M | 7.98M | −926.9K (−10.4%) |
| Value | $142.8M | $71.7M | −$71.1M (−49.8%) |
New holders (5)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock Inc. | 17,999 | $164.0K | 0.00% |
| Renaissance Technologies LLC | 10,400 | $95.0K | 0.00% |
| Advisory Services Network, LLC | 1,000 | $9.00K | 0.00% |
| Wells Fargo & Company | 33 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 38 | $0 | 0.00% |
Sold out (10)
Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Citigroup Inc | 405,645 | $6.62M |
| Citadel Advisors LLC | 181,473 | $2.96M |
| Goldman Sachs Group Inc | 25,000 | $410.0K |
| Davidson Kempner Capital Management LP | 25,000 | $405.0K |
| Endurant Capital Management LP | 16,327 | $267.0K |
| ExodusPoint Capital Management, LP | 15,011 | $246.0K |
| Wellington Management Group LLP | 11,333 | $185.0K |
| Jane Street Group, LLC | 10,606 | $174.0K |
| Maven Securities LTD | 7,813 | $128.0K |
| Bank of America Corp | 404 | $7.00K |